Accelerate Diagnostics Inc AXDX:NASDAQ

RT Quote | NASDAQ | USD
Last | 4:00 PM EST
10.16UNCH (UNCH)
Volume
198,878
52 week range
4.53 - 19.11

...

Loading . . .

KEY STATS

  • Open10.12
  • Day High10.56
  • Day Low9.98
  • Prev Close10.16
  • 52 Week High19.11
  • 52 Week High Date07/16/20
  • 52 Week Low4.53
  • 52 Week Low Date03/20/20
  • Market Cap585.32M
  • Shares Out57.61M
  • 10 Day Average Volume0.35M
  • Dividend-
  • Dividend Yield-
  • Beta2.13
  • 1 Year % Change-20.69

RATIOS/PROFITABILITY

  • EPS (TTM)-1.40
  • P/E (TTM)-7.27
  • Fwd P/E (NTM)-7.83
  • EBITDA (MRQ)-60.705M
  • ROE (MRQ)-837.84%
  • Revenue (MRQ)11.16M
  • Gross Margin (MRQ)39.93%
  • Net Margin (MRQ)-700.54%
  • Debt To Equity (MRQ)-233.11%

EVENTS

  • Earnings Date05/09/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Accelerate Diagnostics Inc News

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Accelerate Diagnostics, Inc. is an in vitro diagnostics company engaged in providing solutions that develop patient outcomes through the diagnosis of serious infections. The Company's in vitro diagnostic platform, the Accelerate Pheno system utilizes genotypic technology to identify (ID), infectious pathogens and phenotypic technology to conduct antibiotic susceptibility testing (AST), which determines whether live bacterial or fungal cells are resistant or susceptible to a...
John Patience
Chairman
John Phillips
Chief Executive Officer
Steve Reichling
Chief Financial Officer
Address
3950 S. Country Club Road #470
Building 3-307
Tucson, AZ
85714-2240
United States